Call for the DZG Innovation Fund 2027/28

DZD News

The DZG Innovation Fund (DZGIF) is a joint research funding program of the German Centers for Health Research (DZG). The topic for the 2027/28 call for proposals is "Immune Dysregulation and Interorgan Mechanisms in Post-Infectious Conditions: Pathogenesis, Biomarkers, and Non-Pharmacological Interventions." To be eligible for funding, the project must involve scientists from at least three DZG.

The aim of the DZGIF is to strengthen networking among its members, facilitate joint research, and thus create interdisciplinary synergies between the DZGs.

With the DZGIF, the centers pool their expertise to enable and finance promising, cross-disease research ideas. In this way, the DZGs aim to promote translation and advance knowledge on the prevention, diagnosis, and treatment of common diseases.

Immune Dysregulation and Interorgan Mechanisms in Post-Infectious Conditions

Scientists from the DZG can apply for the 2027/28 funding period with joint research projects on the topic of “Immune Dysregulation and Interorgan Mechanisms in Post-Infectious Conditions: Pathogenesis, Biomarkers, and Non-Pharmacological Interventions,” which pursue the following research content:

i) Mechanisms of immune dysregulation, autoimmunity, and (genetic/epigenetic) predisposition for specific post-infectious phenotypes

ii) Impact on central nervous mechanisms including cognition, neuroinflammation, neurodegeneration, and overlap with mental disorders

iii) Dysregulation of the autonomic nervous system and cardiovascular alterations including endothelial dysfunction and cardiac inflammation

iv) Mechanisms of post-exertional malaise and mitochondrial muscle/cellular metabolic alterations

v) Disturbance of the microbiome and gut-brain communication

vi) Mechanisms, phenotypes, biomarkers, and therapeutic targets in children and adolescents.

Pathogenesis, Biomarkers, and Non-Pharmacological Interventions

All project proposals should focus on the identification of biomarkers, drug targets, central nervous mechanisms, and the development of more effective non-pharmacological therapeutic strategies.

Dates

  • March 27, 2026: Deadline for submission of the Expression of Interest 
  • April 27, 2026: Partnering Day – the online event brings together all interested DZG scientists

Further information and application documents are available on the DZG website.

Birgit Niesing
Birgit Niesing

Public Relations